BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

411 related articles for article (PubMed ID: 28360517)

  • 21. Prevalence, risk factors, and health-related quality of life of osteoporosis in patients with COPD at a community hospital in Taiwan.
    Lin CW; Chen YY; Chen YJ; Liang CY; Lin MS; Chen W
    Int J Chron Obstruct Pulmon Dis; 2015; 10():1493-500. PubMed ID: 26251589
    [TBL] [Abstract][Full Text] [Related]  

  • 22. A cross-sectional survey of night-time symptoms and impact of sleep disturbance on symptoms and health status in patients with COPD.
    Ding B; Small M; Bergström G; Holmgren U
    Int J Chron Obstruct Pulmon Dis; 2017; 12():589-599. PubMed ID: 28243077
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Myocardial performance index correlates with the BODE index and affects quality of life in COPD patients.
    Tannus-Silva DG; Masson-Silva JB; Ribeiro LS; Conde MB; Rabahi MF
    Int J Chron Obstruct Pulmon Dis; 2016; 11():2261-2268. PubMed ID: 27695314
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Relative impact of COPD and comorbidities on generic health-related quality of life: a pooled analysis of the COSYCONET patient cohort and control subjects from the KORA and SHIP studies.
    Wacker ME; Jörres RA; Karch A; Koch A; Heinrich J; Karrasch S; Schulz H; Peters A; Gläser S; Ewert R; Baumeister SE; Vogelmeier C; Leidl R; Holle R;
    Respir Res; 2016 Jul; 17(1):81. PubMed ID: 27405652
    [TBL] [Abstract][Full Text] [Related]  

  • 25. COPD management: role of symptom assessment in routine clinical practice.
    van der Molen T; Miravitlles M; Kocks JW
    Int J Chron Obstruct Pulmon Dis; 2013; 8():461-71. PubMed ID: 24143085
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Independent determinants of disease-related quality of life in COPD - scope for nonpharmacologic interventions?
    Brien SB; Stuart B; Dickens AP; Kendrick T; Jordan RE; Adab P; Thomas M
    Int J Chron Obstruct Pulmon Dis; 2018; 13():247-256. PubMed ID: 29386893
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Real-life assessment of the multidimensional nature of dyspnoea in COPD outpatients.
    Morélot-Panzini C; Gilet H; Aguilaniu B; Devillier P; Didier A; Perez T; Pignier C; Arnould B; Similowski T
    Eur Respir J; 2016 Jun; 47(6):1668-79. PubMed ID: 27076585
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Gender-associated differences in dyspnoea and health-related quality of life in patients with chronic obstructive pulmonary disease.
    Katsura H; Yamada K; Wakabayashi R; Kida K
    Respirology; 2007 May; 12(3):427-32. PubMed ID: 17539850
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Domain-specific cognitive impairment in patients with COPD and control subjects.
    Cleutjens FA; Franssen FM; Spruit MA; Vanfleteren LE; Gijsen C; Dijkstra JB; Ponds RW; Wouters EF; Janssen DJ
    Int J Chron Obstruct Pulmon Dis; 2017; 12():1-11. PubMed ID: 28031706
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Development of a Standard Set of Outcome Domains and Proposed Measures for Chronic Obstructive Pulmonary Disease in Primary Care Physical Therapy Practice in the Netherlands: a Modified RAND/UCLA Appropriateness Method.
    Verburg AC; van Dulmen SA; Kiers H; Ypinga JH; Nijhuis-van der Sanden MW; van der Wees PJ
    Int J Chron Obstruct Pulmon Dis; 2019; 14():2649-2661. PubMed ID: 31819398
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Burden of smoking on quality of life in patients with chronic obstructive pulmonary disease.
    Galaznik A; Chapnick J; Vietri J; Tripathi S; Zou KH; Makinson G
    Expert Rev Pharmacoecon Outcomes Res; 2013 Dec; 13(6):853-60. PubMed ID: 24219055
    [TBL] [Abstract][Full Text] [Related]  

  • 32. The impact of COPD on quality of life, productivity loss, and resource use among the elderly United States workforce.
    DiBonaventura Md; Paulose-Ram R; Su J; McDonald M; Zou KH; Wagner JS; Shah H
    COPD; 2012 Feb; 9(1):46-57. PubMed ID: 22292597
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Characteristics and health burden of the undiagnosed population at risk of chronic obstructive pulmonary disease in China.
    Koch M; Butt T; Guo W; Li X; Chen Y; Tan D; Liu GG
    BMC Public Health; 2019 Dec; 19(1):1727. PubMed ID: 31870442
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Comparison between COPD Assessment Test (CAT) and modified Medical Research Council (mMRC) dyspnea scores for evaluation of clinical symptoms, comorbidities and medical resources utilization in COPD patients.
    Cheng SL; Lin CH; Wang CC; Chan MC; Hsu JY; Hang LW; Perng DW; Yu CJ; Wang HC;
    J Formos Med Assoc; 2019 Jan; 118(1 Pt 3):429-435. PubMed ID: 30150099
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Validation of the French version of the London Chest Activity of Daily Living scale and the Dyspnea-12 questionnaire.
    Beaumont M; Couturaud F; Jego F; Pichon R; Le Ber C; Péran L; Rogé C; Renault D; Narayan S; Reychler G
    Int J Chron Obstruct Pulmon Dis; 2018; 13():1399-1405. PubMed ID: 29750026
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Functional capacity, physical activity, and quality of life in hypoxemic patients with chronic obstructive pulmonary disease.
    Saglam M; Vardar-Yagli N; Savci S; Inal-Ince D; Calik-Kutukcu E; Arikan H; Coplu L
    Int J Chron Obstruct Pulmon Dis; 2015; 10():423-8. PubMed ID: 25750524
    [TBL] [Abstract][Full Text] [Related]  

  • 37. The MRC dyspnoea scale by telephone interview to monitor health status in elderly COPD patients.
    Paladini L; Hodder R; Cecchini I; Bellia V; Incalzi RA
    Respir Med; 2010 Jul; 104(7):1027-34. PubMed ID: 20116231
    [TBL] [Abstract][Full Text] [Related]  

  • 38. A new functional status outcome measure of dyspnea and anxiety for adults with lung disease: the dyspnea management questionnaire.
    Migliore Norweg A; Whiteson J; Demetis S; Rey M
    J Cardiopulm Rehabil; 2006; 26(6):395-404. PubMed ID: 17135861
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Correlation of the degree of dyspnea with health-related quality of life, functional abilities, and diffusing capacity for carbon monoxide in patients with systemic sclerosis and active alveolitis: results from the Scleroderma Lung Study.
    Khanna D; Clements PJ; Furst DE; Chon Y; Elashoff R; Roth MD; Sterz MG; Chung J; FitzGerald JD; Seibold JR; Varga J; Theodore A; Wigley FM; Silver RM; Steen VD; Mayes MD; Connolly MK; Fessler BJ; Rothfield NF; Mubarak K; Molitor J; Tashkin DP;
    Arthritis Rheum; 2005 Feb; 52(2):592-600. PubMed ID: 15692967
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Predictors of Health-Related Quality of Life (HRQOL) in Patients With Chronic Obstructive Pulmonary Disease using the COPD Assessment Test (CAT).
    Akor AA; Bamidele A; Erhabor GE
    West Afr J Med; 2020; 37(3):275-280. PubMed ID: 32476122
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 21.